We Empower and Support Family Caregivers to Improve Cost and Quality Outcomes for Seniors Who Struggle with Self-Managing their Health.

The Challenge – Seniors Unable to Self-Manage

Seniors who struggle with self-managing their health—for example, due to dementia—often depend on a family caregiver (e.g., a spouse or adult child) to provide or manage their care. Many family caregivers are stressed and lack the knowledge, skills and confidence required to be effective caregivers.

Challenges for Employers

Employers strive to maintain the well-being and productivity of employee caregivers who experience stress, anxiety, guilt, fatigue or depression due to caring for an aging parent.

Challenges for Payers and Providers of Value-Based Care

Seniors who are unable to self-manage their health are also the most expensive patient populations in our healthcare systems. In a typical Medicare Advantage plan, members with dementia incur 25% of all hospitalizations. High costs present challenges for payers and providers of value-based care who lack approaches to effectively integrate family caregivers into the care of loved ones, i.e., members who are unable to effectively engage in traditional care management programs.

Our Digital Health Solutions Empower Family Caregivers

Our novel approach combines technology, content, remote coaching and predictive analytics to empower family caregivers to become more active and effective in managing an aging loved one’s care.

We have integrated this novel approach into two digital health solutions:

  • A Caregiver Portal that supports family caregivers with personalized education, access to support resources and the ability to seek guidance and support from a Ceresti coach.
  • A Value-Based Care Solution that achieves the Triple Aim (improve care, quality, costs) for members with dementia.

Our modular solution can be readily configured to support your specific needs. Contact us today.

Our Solutions are Delivered via Technology & Coaching

Our solutions are delivered via our comprehensive, scalable and secure technology and coaching platform. Family caregivers enrolled in our value-based care programs access their personalized daily plans and risk assessments via a Ceresti tablet that we send to the caregiver’s home, or by App. Families can download Ceresti Connect, an App to communicate with the primary caregiver, access education and reply to caregiver help requests. We offer a caregiver portal to support employee caregivers and those who are earlier in their caregiving journey. Ceresti coaches utilize the Ceresti EHR to empower and support caregivers and their loved ones.

Leadership Team

Ceresti Health is a team of experienced and passionate professionals focused on improving cost and quality outcomes for patients with multiple chronic conditions, starting with those who also have Alzheimer’s Disease or other dementias. We have developed a scalable technology-enabled family caregiver empowerment program that leverages family caregivers to optimize and supplement payer/provider care management teams in managing one of the most expensive, rapidly growing and difficult to manage populations.

Dirk Soenksen

Co-Founder and Chief Executive Officer
Dirk Soenksen

Co-Founder and Chief Executive Officer

Dirk Soenksen is a strategic results-oriented healthcare executive with over 25 years experience. Prior to Ceresti, Mr. Soenksen founded venture-backed Aperio and served in the positions of President/CEO/Chairman until its acquisition by Danaher/Leica Biosystems in 2012. He built a winning team that established Aperio as the recognized global leader in digital pathology, with a staff of 200, a rich portfolio of patents, healthy and growing revenue, multiple FDA clearances, and an installed base of more than 1,000 systems in 35 countries. He earned his AB degree in Chemistry from Bowdoin College, MSEE from the University of Pennsylvania, and his MBA from Pepperdine University.

Mark Wrenn

Co-Founder and Chief Technology Officer
Mark Wrenn

Co-Founder and Chief Technology Officer

Mark Wrenn has over 30 years experience developing reliable and scalable software architectures. Before co-founding Ceresti, Mr. Wrenn was Sr. Director of Product and Business Development at Aperio where he led the development of a global, HIPAA compliant, cloud-based second opinion network for pathology. He also served as Director of Professional Services where he delivered value-added software and services, including interfaces to third-party IT systems, for a pathology PACS. He earned his BSEng in Computer Science from the University of Connecticut.

Chris Selecky

Chief Commercial Officer
Chris Selecky

Chief Commercial Officer

Chris Selecky has more than 30 years of experience in managed care and population health management and is Chair of the Board of the Population Health Alliance, the national trade association of the Population Health industry. She is an innovative and accomplished chief executive and entrepreneur in the healthcare industry including co-founding and growing a market leading disease management company from start-up to $130 million in revenues and leading a $2 billion business unit of a publicly traded managed care organization.

She serves on for-profit boards of directors and provides strategic consulting and advice to management teams and investors currently in or seeking to enter the healthcare field. Her areas of expertise include population health management, wellness and prevention, care coordination, disease management, commercial and Medicare managed care, and delivery system management.

Rob Lonardo

Chief Growth Officer
Rob Lonardo

Chief Growth Officer

Rob Lonardo has more than 35 years of experience in managed care with an emphasis on Medicare Advantage, Dual Eligibles and SPD (Seniors and Persons with Disabilities) populations.  Rob’s career has included leadership roles at  FHP Healthcare, Blue Shield of California and running a large IPA serving the Inland Empire and San Diego markets.  Rob led CareMore Medical Enterprises for nearly 6 years, initially working for its physician owners, and subsequently running Growth and Business Development after Anthem’s acquisition of CareMore.  Most recently, he worked at Alignment Healthcare in Orange, CA serving in multiple leadership roles.

Rob has a true passion for changing the way care is delivered, particularly to seniors.  He has been a leader in improved coordination of care, better use of technology, using data to help health plans ‘find’ the patients that need them most, and assuring that every member with any disease or condition gets the care they need when and where it should be delivered.

Gordon Norman, MD

Chief Medical Officer
Gordon Norman, MD

Chief Medical Officer

Dr. Norman has 30 years of experience in population health, value-based care, and provider transformation.  His career has focused on supporting provider & health systems, ACOs, and health plans as they pivot to the value-based care era where cost efficiency, quality outcomes, and experience of care are balanced to formulate the overall value of health care delivery.

Most recently, Dr. Norman led the Health System Consulting practice at Willis Towers Watson where he worked directly with health systems transitioning to value-based care.  Previously, he served as Chief Medical Officer for xG Health Solutions, where he adapted and disseminated the value-based care know-how and tools developed by Geisinger Health System for other delivery systems transforming from fee-for-volume to fee-for-value care models.  Before that, he held a series of executive leadership roles in multiple sectors of the healthcare ecosystem, with a consistent focus on population health management and value improvement.

Aligning Better Patient Care with Finding a Cure

While we are squarely focused on improving patient care and reducing healthcare costs, our broader mission is to change the conversation around dementia. We believe there is a compelling opportunity to align Ceresti’s solutions with national initiatives aimed at finding a cure for Alzheimer’s Disease. For example, our Value-Based Care Solution can potentially reduce U.S. healthcare costs by hundreds of billions of dollars over the course of a decade. Redirecting these savings to finding a cure could result in a more than 10-fold increase over current funding levels.

We also believe that our solutions could be deployed with new or existing treatment agents to enable new treatments for Alzheimer’s Disease, a disease area that has seen no new drug approvals since 2003.